Your browser doesn't support javascript.
loading
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.
Zhou, L; Liu, X-D; Sun, M; Zhang, X; German, P; Bai, S; Ding, Z; Tannir, N; Wood, C G; Matin, S F; Karam, J A; Tamboli, P; Sircar, K; Rao, P; Rankin, E B; Laird, D A; Hoang, A G; Walker, C L; Giaccia, A J; Jonasch, E.
Afiliação
  • Zhou L; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Liu XD; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sun M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang X; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • German P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bai S; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ding Z; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tannir N; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wood CG; Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Matin SF; Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Karam JA; Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tamboli P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sircar K; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rao P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rankin EB; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Laird DA; Exelixis Inc., South San Francisco, CA, USA.
  • Hoang AG; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Walker CL; Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX, USA.
  • Giaccia AJ; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Jonasch E; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Oncogene ; 35(21): 2687-97, 2016 05.
Article em En | MEDLINE | ID: mdl-26364599
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirróis / Carcinoma de Células Renais / Proteínas Proto-Oncogênicas / Receptores Proteína Tirosina Quinases / Proteínas Proto-Oncogênicas c-met / Inibidores da Angiogênese / Indóis / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirróis / Carcinoma de Células Renais / Proteínas Proto-Oncogênicas / Receptores Proteína Tirosina Quinases / Proteínas Proto-Oncogênicas c-met / Inibidores da Angiogênese / Indóis / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos